Collective X Health has emerged from stealth with a $3.2 million pre-seed round. The company, co-founded by exercise physiologist Dr Stacy Sims, says it turns research on female physiology into structured intelligence that other health and performance products can access through an API. Human Powered Health and Altra Running are named founding customers.

“Women have been systematically excluded from health research”

Dr Stacy Sims, Co-Founder and Chief Research Officer, Collective X Health

A shared research layer

The company positions its service as infrastructure for other products. Its stated approach combines source citations with research reviewed by a collective of scientific and clinical specialists. These are descriptions of the platform from its launch announcement, rather than independent findings about the accuracy of every answer it produces.

The evidence gap needs careful definition

NIH’s Office of Research on Women’s Health says women now represent roughly half of participants in NIH-supported clinical research. It also identifies a longstanding reliance on male animals and cells in basic and preclinical work. NIH policy expects researchers to consider sex in study design, analysis and reporting.

That distinction matters: the problem cannot be reduced to a claim that women are absent from all modern research. For a commercial evidence service, the practical test is how it handles the gaps that remain, conflicting studies and findings that do not generalize to a particular age, condition or population.

A shared evidence service could reduce the work each digital-health team repeats when building women’s health features. Its value will depend on the quality of the underlying research and on how faithfully software communicates uncertainty. A citation is a useful starting point; it does not, by itself, validate the advice or the product using it.

Independent evaluations, transparent study-selection criteria, update and correction processes, and performance across populations and life stages. It will also matter whether downstream products preserve source context and distinguish general information from individualized clinical guidance.